A detailed history of Mor Wealth Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Mor Wealth Management, LLC holds 249,265 shares of IBRX stock, worth $518,471. This represents 0.23% of its overall portfolio holdings.

Number of Shares
249,265
Holding current value
$518,471
% of portfolio
0.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 14, 2026

BUY
$2.0 - $2.66 $498,530 - $663,044
249,265 New
249,265 $494 Million

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $833M
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Mor Wealth Management, LLC Portfolio

Follow Mor Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mor Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mor Wealth Management, LLC with notifications on news.